| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3165529 | Oral Oncology | 2009 | 7 Pages |
Abstract
SummaryIn recent years targeted therapies have expanded treatment options for patients with squamous cell cancer of the head and neck (SCCHN) considerably and have led to clinically significant benefit. However, the multitude of new targeted drugs that have emerged and are in development also represent a challenge and many years of carefully conducted clinical studies will be needed to explore their full potential. This article summarizes the most important recent developments in the targeted treatment of SCCHN and provides an overview of pathways and promising potential targets that could impact the treatment of patients with SCCHN in the future.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Jochen H. Lorch, Marshall R. Posner, Lori J. Wirth, Robert I. Haddad,